Exploring Immune-Related Adverse Events: A Case of Febrile Neutropenia in a Melanoma Patient Receiving Immunotherapy

Exploring Immune-Related Adverse Events: A Case of Febrile Neutropenia in a Melanoma Patient Receiving Immunotherapy

Introduction: The introduction of immune checkpoint inhibitors (ICIs) has opened a new chapter in cancer treatment. Nevertheless, their use may result in immune-related adverse events (irAEs) with multifactorial determinants, complex mechanisms, and varying clinical implications. In specific cancer...

Full description

Bibliographic Details
Main Authors: Melina Yerolatsite, Nanteznta Torounidou, Anna-Lea Amylidi, Fani Kapoulitsa, Eleftherios Kampletsas, George Zarkavelis, Davide Mauri
Format: Article
Language:English
Published: Karger Publishers 2024-03-01
Series:Case Reports in Oncology
Subjects:
immune checkpoint inhibitors
immune-related adverse events
neutropenia
melanoma
case report
ctla-4
pd-1
Online Access:https://beta.karger.com/Article/FullText/536288

Similar Items

Similar Items